Loading page…
Search companies, filings, portfolio…
⌘K
Sign in
Sign up
SP
Symbiotec Pharmalab Limited
NSE:
SYMBIOTEC
BSE:
SYMBIOTEC
Healthcare
Pharmaceuticals & Biotechnology
₹1,198.0
+1.81%
1 Oct close
Mkt cap
₹7,703 Cr
Watch
Alert
Compare
Overview
Chart
Peers
Profit & loss
Balance sheet
Cash flow
Ratios
Shareholding
F&O
Fund holders
Documents
Events
Announcements
Notes
Annual
Quarterly
Consolidated
Standalone
Standalone figures · ₹ crore
Quarterly results
₹ Cr
Jun 2026
Revenue
211
COGS
78
Gross profit
132
Operating expenses
+
73
Operating profit (EBITDA)
+
59
OPM %
28.1%
Depreciation
10
Interest
6
Other income
+
20
Profit before tax
63
Tax
16
Tax %
25.4%
PAT
47
PAT margin %
22.3%
EPS (₹)
7.5
Results filing
Results filing for Jun 2026